These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7271805)

  • 1. Phosphorylation and anti-leishmanial activity of formycin B.
    Carson DA; Chang KP
    Biochem Biophys Res Commun; 1981 Jun; 100(3):1377-83. PubMed ID: 7271805
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism and mechanism of action of formycin B in Leishmania.
    Rainey P; Santi DV
    Proc Natl Acad Sci U S A; 1983 Jan; 80(1):288-92. PubMed ID: 6572004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Leishmania spp: formycin B treatment of cutaneous leishmaniasis in mice.
    Rojas T; Avila JL
    Parasitology; 1987 Jun; 94 ( Pt 3)():467-74. PubMed ID: 3614989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antileishmanial activity of human red blood cells containing formycin A.
    Berman JD; Gallalee JV
    J Infect Dis; 1985 Apr; 151(4):698-703. PubMed ID: 3973416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monophosphates of formycin B and allopurinol riboside. Interactions with leishmanial and mammalian succino-AMP synthetase and GMP reductase.
    Spector T; Jones TE; LaFon SW; Nelson DJ; Berens RL; Marr JJ
    Biochem Pharmacol; 1984 May; 33(10):1611-7. PubMed ID: 6732835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolism of formycin B in Leishmania donovani.
    Nelson DJ; Lafon SW; Jones TE; Spector T; Berens RL; Marr JJ
    Biochem Biophys Res Commun; 1982 Sep; 108(1):349-54. PubMed ID: 7150292
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental chemotherapy of leishmaniasis with adenosine analogue Formycin A, in combination with inhibitor of nucleoside transport, nitrobenzylthioinosinate.
    Ogbunude PO; al-Jaser MH
    Drugs Exp Clin Res; 1992; 18(10):423-6. PubMed ID: 1306154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formycin B resistance in Leishmania.
    Rainey P; Santi DV
    Biochem Pharmacol; 1984 Apr; 33(8):1374-7. PubMed ID: 6712743
    [No Abstract]   [Full Text] [Related]  

  • 9. Leishmania donovani: oral efficacy and toxicity of formycin B in the infected hamster.
    Berman JD; Keenan CM; Lamb SR; Hanson WL; Waits VB
    Exp Parasitol; 1983 Oct; 56(2):215-21. PubMed ID: 6617804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of formycin B by Leishmania amastigotes in vitro. Comparative metabolism in infected and uninfected human macrophages.
    Berman JD; Rainey P; Santi DV
    J Exp Med; 1983 Jul; 158(1):252-7. PubMed ID: 6190980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of antimony-resistant Leishmania to alternative drugs.
    Berman JD
    J Infect Dis; 1982 Feb; 145(2):279. PubMed ID: 6274970
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-leishmanial effect of allopurinol ribonucleoside and the related compounds, allopurinol, thiopurinol, thiopurinol ribonucleoside, and of formycin B, sinefungin and the lepidine WR6026.
    Neal RA; Croft SL; Nelson DJ
    Trans R Soc Trop Med Hyg; 1985; 79(1):122-8. PubMed ID: 3992630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical genetic analysis of formycin B action in Leishmania donovani.
    Robinson N; Kaur K; Emmett K; Iovannisci DM; Ullman B
    J Biol Chem; 1984 Jun; 259(12):7637-43. PubMed ID: 6203896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of formycin B on mRNA translation and uptake of purine precursors in Leishmania mexicana.
    Nolan LL; Berman JD; Giri L
    Biochem Int; 1984 Aug; 9(2):207-18. PubMed ID: 6207832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The catalytic site of AMP nucleosidase. Substrate specificity and pH effects with AMP and formycin 5'-PO4.
    DeWolf WE; Fullin FA; Schramm VL
    J Biol Chem; 1979 Nov; 254(21):10868-75. PubMed ID: 40976
    [No Abstract]   [Full Text] [Related]  

  • 16. Leishmania tropica: quantitation of in vitro activity of antileishmanial agents by Giemsa staining, viability, and 3H-formycin B incorporation.
    Berman JD
    J Parasitol; 1984 Aug; 70(4):561-2. PubMed ID: 6502359
    [No Abstract]   [Full Text] [Related]  

  • 17. Difluoromethylornithine and formycin B in toxoplasmosis.
    Hofflin JM; Guptill DR; Araujo FG; Remington JS
    J Infect Dis; 1985 Nov; 152(5):1101. PubMed ID: 3930627
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of allopurinol ribonucleoside and formycin B on Trypanosoma cruzi infections in mice.
    Croft SL; Neal RA
    Trans R Soc Trop Med Hyg; 1985; 79(4):517-8. PubMed ID: 3936241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase activities in Leishmania aethiopica: control by growth, transformation and inhibitors.
    Assefa D; Worku Y; Skoglund G
    Biochim Biophys Acta; 1995 Apr; 1270(2-3):157-62. PubMed ID: 7727538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic phosphates of formycin.
    Makabe O; Miyadera A; Kinoshita M; Umezawa S
    J Antibiot (Tokyo); 1978 May; 31(5):456-67. PubMed ID: 209007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.